文献速递心脑血管急症重症综合管理与镇静镇痛

Eurotherm3235试验中创伤性脑损伤后的死亡风险分层与滴定低温治疗的死亡风险

Mortality Risk Stratification After Traumatic Brain Injury and Hazard of Death With Titrated Hypothermia in the Eurotherm3235Trial.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论Eurotherm3235试验事后分析显示,低温作为降低颅内压的一线措施在低风险患者中可能有害,在更严重损伤患者中无明确获益。

该研究是对Eurotherm3235试验的事后分析,该试验为随机对照试验,采用标准化盲法结局评估,在18个国家47个神经重症监护病房纳入成人闭合性创伤性脑损伤、颅内压升高、初始头部损伤小于10天、核心体温至少36°C且脑CT异常的患者。将患者按IMPACT扩展模型总分分为风险三分位,在意向治疗人群(386例)和符合方案人群(257例)中,按干预和IMPACT扩展模型总分三分位进行从随机化到6个月死亡的比例风险分析。结果显示,在全部风险分层中治疗效应表现相似,但存在趋势表明低风险组患者可能因低温而承受更大伤害风险。结论认为,低温作为降低颅内压至小于20 mm Hg的一线措施,在损伤严重程度较低的患者中有害,在更严重损伤患者中无明确获益。

要点

  • 在Eurotherm3235试验意向治疗人群386例和符合方案人群257例中,按IMPACT扩展模型总分三分位分层后,低温的治疗效应在所有风险分层中表现相似。
  • 存在趋势表明,低风险组患者可能因低温而承受更大伤害风险。
  • 低温作为降低颅内压至小于20 mm Hg的一线措施,在损伤严重程度较低的患者中有害,在更严重损伤患者中无明确获益。
  • 该分析为Eurotherm3235试验的事后风险分层分析,采用意向治疗和符合方案两种人群进行分析。

适用人群与场景

  • 纳入标准:成人创伤性脑损伤患者,入住重症监护病房,原发性闭合性创伤性脑损伤,颅内压升高,初始头部损伤小于10天,核心体温至少36°C,脑CT异常。
  • 研究场景:18个国家47个神经重症监护病房。

诊断标准与关键阈值

  • 按IMPACT扩展模型总分将患者分为风险三分位。
  • 低温治疗目标:核心体温32-35°C,作为降低颅内压的主要干预措施。
  • 颅内压目标:降低至小于20 mm Hg。

处置流程与药物剂量

  • 滴定低温范围32-35°C作为降低颅内压的主要干预措施。

研究设计与关键结果

  • 研究类型:Eurotherm3235试验的事后分析,该试验为随机对照试验,采用标准化盲法结局评估;共47个神经重症监护病房,18个国家。
  • 分析人群:意向治疗人群386例,符合方案人群257例。
  • 主要分析:按干预和IMPACT扩展模型总分三分位进行从随机化到6个月死亡的比例风险分析。
  • 结果:在全部风险分层中治疗效应表现相似;存在趋势表明低风险组患者可能因低温而承受更大伤害风险。

证据类型、等级与局限

  • 证据类型:随机对照试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 低温作为降低颅内压至小于20 mm Hg的一线措施,在损伤严重程度较低的患者中有害,在更严重损伤患者中无明确获益。

指南或共识出处

  • Eurotherm3235试验

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Hypothermia reduces intracranial hypertension in patients with traumatic brain injury but was associated with harm in the Eurotherm3235Trial. We stratified trial patients by International Mission for Prognosis and Analysis of Clinical Trials in [Traumatic Brain Injury] (IMPACT) extended model sum scores to determine where the balance of risks lay with the intervention.

DESIGN: The Eurotherm3235Trial was a randomized controlled trial, with standardized and blinded outcome assessment. Patients in the trial were split into risk tertiles by IMPACT extended model sum scores. A proportional hazard analysis for death between randomization and 6 months was performed by intervention and IMPACT extended model sum scores tertiles in both the intention-to-treat and the per-protocol populations of the Eurotherm3235Trial.

SETTING: Forty-seven neurologic critical care units in 18 countries.

PATIENTS: Adult traumatic brain injury patients admitted to intensive care who had suffered a primary, closed traumatic brain injury; increased intracranial pressure; an initial head injury less than 10 days earlier; a core temperature at least 36°C; and an abnormal brain CT.

INTERVENTION: Titrated Hypothermia in the range 32-35°C as the primary intervention to reduce raised intracranial pressure.

MEASUREMENTS AND MAIN RESULTS: Three hundred eighty-six patients were available for analysis in the intention-to-treat and 257 in the per-protocol population. The proportional hazard analysis (intention-to-treat and per-protocol populations) showed that the treatment effect behaves similarly across all risk stratums. However, there is a trend that indicates that patients in the low-risk group could be at greater risk of suffering harm due to hypothermia.

CONCLUSIONS: Hypothermia as a first line measure to reduce intracranial pressure to less than 20 mm Hg is harmful in patients with a lower severity of injury and no clear benefit exists in patients with more severe injuries.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Andrews PJD, Rodriguez A, Suter P, et al. Mortality Risk Stratification After Traumatic Brain Injury and Hazard of Death With Titrated Hypothermia in the Eurotherm3235Trial. Crit Care Med. 2017. PMID: 28277415. doi:10.1097/CCM.0000000000002376

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。